Investigational Treatment for MS Shows Efficacy in People with Primary Progressive MS
- F. Hoffmann-La Roche. ClinicalTrials.gov NCT01194570. National Library of Medicine. Available at: https://clinicaltrials.gov/ct2/show/NCT01194570.
- F. Hoffmann-La Roche. ClinicalTrials.gov NCT01247324 and NCT01412333. National Library of Medicine. Available at: https://clinicaltrials.gov/ct2/show/NCT01247324 and https://clinicaltrials.gov/ct2/show/NCT01412333.
- Roche's ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosis in large Phase III study. Fierce Biotech. September 28, 2015. Available at: http://www.fiercebiotech.com/press-releases/roches-ocrelizumab-first-investigational-medicine-show-efficacy-people-prim.